Treatment by uninterrupted positive airway pressure by nasal route - Evaluation of REMstar® Auto with C-Flex in clinical practice

Respironics International (France)0 个研究点目标入组 20 人开始时间: 2008年11月20日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Past experience of treatment with positive airway pressure or non invasive ventilation
•2. Participants who require 2 levels of pressure for nocturnal alveolar hypoventilation linked to a co-morbidity (obesity, hypoventilation, chronic obstructive pulmonary disease [COPD]) of sleep aponea/ hypopnoea syndrome
•3. Participants that have undergone surgery for the treatment of sleep apnoea/ hypopnoea syndrome, snore or tumour in the last 6 months or after their polysomnography (PSG) diagnosis
•4. Tracheostomy
•5. Respiratory infection, sinusitis or internal ear infection
•6. Dermatitis or other facial lesions preventing the application of a mask
•7. Unable to give written informed consent
•8. Participants unwilling to volunteer
•9. Unstable medication
•10. Participants presenting with clinically significant COPD or unstable cardiac insufficiency
•11. People benefiting from a reinforced protection will not be included in this study. This refers to subjects protected by law, persons accepted in a health or social establishment, private individuals of freedom by a court or administrative order, ill in urgent situation, and persons hospitalised without consent.
•12. Participants should not have participated in a trial in the 3 months preceding or following the study

发起方

Respironics International (France)